Main Street Planning Group 180 East Main Street Suite 110 Patchogue, NY 11772 Tel: 631.647.4694 Fax: 631.647.4697 MainStreetPlanningGroup.



Similar documents
Leukemias and Lymphomas: A primer

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Medicare Coverage of Genomic Testing

Update in Hematology Oncology Targeted Therapies. Mark Holguin

What is a Stem Cell Transplantation?

Lauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?

Advancing Therapies for Blood Cancers

ACUTE MYELOID LEUKEMIA (AML),

New strategies in anticancer therapy

How To Know If You Have Cancer At Mercy Regional Medical Center

How CanCer becomes critical in the claims

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS

Probe: Could you tell me about when?

Pediatric Oncology for Otolaryngologists

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?

Leukemia and Exposure to Ionizing Radiation

Radiation Therapy for Cancer Treatment

SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR.

The Treatment of Leukemia

NEOPLASMS C00 D49. Presented by Jan Halloran CCS

Acute myeloid leukaemia (AML) in children

Breast Cancer. Presentation by Dr Mafunga

Adjuvant Therapy for Breast Cancer: Questions and Answers

Colon and Rectal Cancer

MALIGNANT LYMPHOMAS. Dr. Olga Vujovic (Updated August 2010)

Cancer in Children. What is cancer?

Acute Myeloid Leukemia

Endometrial Cancer Treatment

Report series: General cancer information

Cancer Treatment & Survivorship Facts & Figures

Cancer Treatment & Survivorship Facts & Figures

Cancer is the leading cause of death for Canadians aged 35 to 64 and is also the leading cause of critical illness claims in Canada.

Oncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control

information for payers and referrers

Understanding your pathology report

Malignant Lymphomas and Plasma Cell Myeloma

RADIATION THERAPY FOR LYMPHOMA. Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY

CHAPTER 2. Neoplasms (C00-D49) March MVP Health Care, Inc.

Metastatic breast cancer with secondary tumours: advice for patients and relatives

Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each

Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla

dedicated to curing BREAST CANCER

Policy Wording. Together, all the way.

Understanding Metastatic Disease

Follow-up care plan after treatment for breast cancer. A guide for General Practitioners

Ovarian Cancer. in Georgia, Georgia Department of Human Resources Division of Public Health

MEDICAL COVERAGE POLICY

Guideline for the Follow Up of Patients Following Treatment for Breast Cancer

Talking With Your Doctor About Multiple Myeloma: A guide to making the most of your healthcare visits

Mesothelioma , The Patient Education Institute, Inc. ocft0101 Last reviewed: 03/21/2013 1

THYROID CANCER. I. Introduction

Interesting Case Series. Periorbital Richter Syndrome

Leukaemia and lymphoma what s the difference?

Treatment of low-grade non-hodgkin lymphoma

Level 1. Nutrition & Lifestyle Oncology Certificate

C a nc e r C e nter. Annual Registry Report

Follow-Up Care for Breast Cancer

Adult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2

Cancer Drug Coverage: Putting IV and Orally Administered Drugs on an Equal Footing. Deb Maskens Kidney Cancer Canada

PROTOCOLS FOR TREATMENT OF MALIGNANT LYMPHOMA

Remember: Not everyone experiences these persistent and late side effects.

A Checklist for Patients with Breast Cancer

One out of every two men and one out of every three women will have some type of cancer at some point during their lifetime. 3

Cancer. 9p21.3 deletion. t(12;21) t(15;17)

Follow-Up Care for Endometrial (Uterus) Cancer after Discharge from the Cancer Center

Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy

I was just diagnosed, so my doctor and I are deciding on treatment. My doctor said there are several

Total Cost of Cancer Care by Site of Service: Physician Office vs Outpatient Hospital

Acute myeloid leukemia (AML)

Breakthrough Treatment Options for Breast Cancer

The TV Series. INFORMATION TELEVISION NETWORK

Oncology Best Practice Documentation

Increasing Patient Access through Oral Parity Legislation

Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006

Understanding Leukemia

Guide to Understanding Breast Cancer

Second Cancers in Adults

Cutaneous Lymphoma FAST FACTS

I will be having surgery and radiation treatment for breast cancer. Do I need drug treatment too?

METROPOLITAN LIFE INSURANCE COMPANY NEW YORK, NEW YORK

False positive PET in lymphoma

1400 Telegraph Bloomfield Hills, MI Phone number/ fax Number CANCER TREATMENT

Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT

Lymphoma Diagnosis and Classification

4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma

What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals

National Cancer Institute

HAVE YOU BEEN NEWLY DIAGNOSED with DCIS?

The Role of Clinical Practice Guidelines, Survivorship Care Plans, and Inter-sectoral Care in Cancer Rehabilitation

An Introduction to PROSTATE CANCER

Cancer in Children. What is cancer?

AMERICAN HERITAGE LIFE INSURANCE COMPANY (AHL) 1776 AMERICAN HERITAGE LIFE DRIVE JACKSONVILLE, FLORIDA 32224

Early Prostate Cancer: Questions and Answers. Key Points

Flow Cytometric Diagnosis of Low Grade B-cell Leukemia/Lymphoma

Tubular breast cancer

Your Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer

METROPOLITAN LIFE INSURANCE COMPANY 200 PARK AVENUE, NEW YORK, NEW YORK

Kidney Cancer OVERVIEW

Transcription:

Main Street Planning Group 180 East Main Street Suite 110 Patchogue, NY 11772 Tel: 631.647.4694 Fax: 631.647.4697 MainStreetPlanningGroup.com

Presented by Ted Mageau Ted@MainStreetPlanningGroup.com

Life Insurance and Cancer Clients perception vs. reality Evolving underwriting philosophy: yesterday, today and tomorrow Some important factors in underwriting a client: type, location, stage, grade, metastasis, timeframes, treatment (prior and current), client age, etc. Many possible underwriting outcomes Not all insurance companies are the same How do you begin to look into insurance? What not to do. Alternative insurance solutions: using your business or workplace to obtain insurance

Client Perception vs. Reality WHAT CUSTOMERS TELL US WHAT UNDERWRITERS KNOW

Evolving Underwriting Philosophy: Yesterday, Today and Tomorrow Type of Cancer Previous Underwriting Decision Today s Underwriting Decision Thyroid Cancer Papillary or follicular some Stage I or II Postpone 1 year and then significant surcharge Possible Preferred after Standard for ten years Possible Standard immediately following successful treatment Possible Preferred after standard for five years Uterine Cancer Significant surcharge or a decline Endometrial Stage IA or IB well or moderately differentiated Possible Standard immediately following successful treatment Testicular Cancer Seminoma Stage I Significant surcharge Possible Preferred after Standard for ten years Possible Standard immediately following successful treatment Possible Preferred after standard for five years

Some Important Factors in Underwriting a Client: Type Location Stage Grade Metastasis Timeframes Treatment (Prior and Current) Client Age, etc. What the Company Needs to Know: When first diagnosed? What kind of treatments were performed and when did treatment end? What medications are you currently taking? Have follow up tests been normal?

Many Possible Underwriting Outcomes Ex.1 - CANCER - BREAST Action will vary according to the stage (size) and grade (often described as well, moderately or poorly differentiated), as well as metastasis (spread) of the cancer. The timeframes given are measured from the point at which all curative treatment is completed. Continued use of endocrine therapy is acceptable. Stage I May be considered after 1 year. Others, including recurrent breast cancer, may be considered after a longer waiting period, depending on stage, grade and metastasis. Ex. 2 - CANCER LEUKEMIA Acute Lymphocytic Leukemia (ALL) and Acute Myelogenous Leukemia (AML) may be considered five years after completion of successful treatment. Chronic Lymphocytic Leukemia (CLL) or Hairy-Cell Leukemia (HCL) High stage is uninsurable at all ages. Low stage may be considered with diagnosis at age 50. Chronic Myelogenous Leukemia (CML) diagnosed at ages 60 and over, treated with medication, may be considered depending on the age at diagnosis, and may be individually considered with diagnosis between the ages of 55 and 59. Ex. 3 - HODGKIN LYMPHOMA Action will vary according to the stage of the disease, which is measured by the number and location of lymph node regions or other sites involved, in addition to the presence or absence of symptoms. The timeframes given are measured from the point at which all curative treatment (chemotherapy, radiation therapy) is completed. Disease on one side of the diaphragm only Localized disease, no symptoms, may be considered within one year after completion of therapy with diagnosis under age 50 and two years after completion of therapy with diagnosis at ages 50 and over. Localized disease with symptoms may be considered two or three years after completion of therapy. Disease on both sides of the diaphragm With no symptoms, may be considered two or five years after completion of therapy, depending on age at diagnosis and current age.

Not All Insurance Companies are the Same Company philosophies vary Based on historical experience It is critical to work with an insurance specialist with access to multiple carriers Carrier A Carrier B Carrier C

How Do You Begin to Look Into Insurance? What to Do and What Not to Do. What to Do: Find a professional Research Multiple policies are okay Informal application What Not to Do: Omit pertinent information Apply to a company(ies) without research Assume

Alternative Insurance Solutions: Using Your Business or Workplace to Obtain Insurance Your group insurance Voluntary worksite Other possible solutions.